ADAPTIMMUNE THERAPEUTICS PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.185 USD | +10.23% |
|
+16.83% | +48.80% |
Chart calendar Adaptimmune Therapeutics plc
37cd50698dc5526a7fcc3bd5d.mA1XElO7J_xFagnLksGc-8L3ZOWs_kOBsDGFhh8Petc.9X1keBTKa8gPWFaa16PXjKu9I9T2jg2x1kPUsHhYOKTUPzJTAtZytxo9bg~b41c0068fd4defb64263bdba72cf8517
Upcoming events on Adaptimmune Therapeutics plc
Past events on Adaptimmune Therapeutics plc
| 18/04/2024 07:00 pm | Investor Day |
| 08/04/2024 05:30 pm | Needham Virtual Healthcare Conference |
| 26/03/2024 | H.C. Wainwright Cell Therapy Virtual Conference |
| 12/03/2024 11:10 pm | Leerink Partners Global Biopharma Conference |
| 06/03/2024 06:30 pm | Q4 2023 Earnings Call |
| 06/03/2024 05:30 pm | Q4 2023 Earnings Release |
| 04/03/2024 09:00 pm | TD Cowen Health Care Conference |
| 09/02/2024 12:00 am | Guggenheim Healthcare Talks Biotechnology Conference |
| 11/01/2024 09:45 pm | JPMorgan Healthcare Conference |
| 08/11/2023 06:30 pm | Q3 2023 Earnings Call |
| 08/11/2023 06:00 pm | Q3 2023 Earnings Release |
| 27/09/2023 06:05 pm | Cantor Global Healthcare Conference |
| 09/08/2023 05:30 pm | Q2 2023 Earnings Call |
| 09/08/2023 04:59 pm | Q2 2023 Earnings Release |
| 03/06/2023 11:45 pm | American Society of Clinical Oncology Conference |
| 02/06/2023 05:30 pm | Business Update Call |
| 16/05/2023 04:30 pm | Annual General Meeting |
| 12/05/2023 05:30 pm | Q1 2023 Earnings Call |
| 12/05/2023 04:59 pm | Q1 2023 Earnings Release |
| 17/04/2023 07:00 pm | American Association for Cancer Research Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,12 1,92 -41.56% | 3,96 3,29 20.18% | 6,15 111 -94.44% | 27,1 25,5 6.63% | 60,3 86,1 -29.95% | 87,8 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -158 -170 6.96% | -130 -81,7 -59% | -63,3 |
|
EBIT Million USD | Released Forecast Spread | -140 -145 3.77% | -133 -132 -0.96% | -162 -159 -2.04% | -164 -172 4.53% | -140 -105 -33.04% | -86,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -137 -146 6.26% | -130 -129 -0.91% | -157 -156 -0.64% | -163 -160 -2.15% | -113 -74,3 -51.53% | -81,2 |
|
Net income Million USD | Released Forecast Spread | -137 -146 6.24% | -130 -129 -0.96% | -158 -82,7 -91.16% | -165 -165 -0.41% | -114 -83,2 -36.95% | -88,2 |
|
EPS USD | Released Forecast Spread | -1,32 -1,35 2.22% | -0,90 -0,90 0.37% | -1,02 -0,52 -96.15% | -1,02 -1,07 4.67% | -0,54 -0,33 -63.64% | -0,37 |
| Announcement Date | 27/02/20 | 25/02/21 | 14/03/22 | 06/03/23 | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,42 106 -98.66% | 3,58 5,00 -28.5% | 5,54 10,1 -45.17% | 7,01 5,00 40.14% | 11,0 5,08 116.94% | 47,6 | 5,13 6,68 -23.15% | 7,32 15,1 -51.66% | 0,23 26,0 -99.11% | 20,5 | 25,7 | 14,9 | 26,8 | 15,9 |
|
EBIT Million USD | Released Forecast Spread | -42,9 -39,6 -8.24% | -50,0 -42,5 -17.69% | -43,8 -49,0 10.71% | -43,0 -45,2 4.95% | -27,2 -42,1 35.29% | 1,66 | -44,9 -42,4 -5.83% | -46,6 -30,2 -54.26% | -49,9 -15,1 -229.3% | -23,6 | -16,6 | -29,7 | -17,1 | -32,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -38,6 -37,6 -2.79% | -49,6 -39,7 -25.02% | -44,1 -49,0 10.1% | -41,0 -38,9 -5.46% | -28,3 -38,0 25.64% | 1,66 | -20,7 -47,6 56.49% | -44,9 -29,0 -54.88% | -48,6 -10,3 -370.06% | -22,1 | -15,4 | -28,2 | -15,5 | -32,3 |
|
Net income Million USD | Released Forecast Spread | -38,9 36,5 -206.46% | -50,3 -39,8 -26.29% | -44,5 -41,4 -7.67% | -41,4 -38,9 -6.48% | -29,3 -38,0 23.03% | 1,04 | -21,4 -47,9 55.35% | -45,6 -32,0 -42.39% | -47,9 -17,2 -178.59% | -23,4 | -18,2 | -28,6 | -18,1 | -32,3 |
|
EPS USD | Released Forecast Spread | -0,24 0,25 -197.96% | -0,30 -0,25 -22.45% | -0,05 -0,26 80.77% | -0,04 -0,24 83.33% | -0,18 -0,23 20% | 0,00 -0,14 - | -0,12 -0,21 42.86% | -0,03 -0,19 83.93% | -0,24 0,00 - | -0,08 | -0,09 | -0,10 | -0,09 | -0,14 |
| Announcement Date | 14/03/22 | 09/05/22 | 04/08/22 | 08/11/22 | 06/03/23 | 12/05/23 | 09/08/23 | 08/11/23 | 06/03/24 | - | - | - | - | - |
More events
Past sector events for Adaptimmune Therapeutics plc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ADAP Stock
- Calendar Adaptimmune Therapeutics plc
